Warehouse robotics maker Symbotic's Q4 revenue beats estimates

Reuters
2025/11/25
Warehouse robotics maker Symbotic's Q4 revenue beats estimates

Overview

  • Symbotic fiscal Q4 revenue rose to $618 mln, beating analyst expectations

  • Company reported a net loss of $19 mln for fiscal Q4, compared to a profit last year

  • Cash and cash equivalents increased by $467 mln from the prior quarter

Outlook

  • Symbotic expects Q1 fiscal 2026 revenue of $610 mln to $630 mln

  • Company forecasts Q1 fiscal 2026 adjusted EBITDA of $49 mln to $53 mln

Result Drivers

  • REVENUE GROWTH - Revenue exceeded expectations, per CFO Izzy Martins

  • NEW CUSTOMER - Entry into healthcare vertical with Medline as a new customer, broadening opportunities, per CEO Rick Cohen

  • MARGIN EXPANSION - Achieved strong gross margin expansion in Q4, contributing to financial performance, per CFO Izzy Martins

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$618.46 mln

$606.30 mln (16 Analysts)

Q4 Net Income

-$19.15 mln

Q4 Gross Profit

$127.12 mln

Q4 Operating Expenses

$148.88 mln

Q4 Operating Income

-$21.76 mln

Q4 Pretax Profit

-$13.69 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy", 10 "hold" and 3 "sell" or "strong sell"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy."

  • Wall Street's median 12-month price target for Symbotic Inc is $53.00, about 1.2% below its November 21 closing price of $53.64

Press Release: ID:nGNX1YkbFC

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10